Astrana Health, Inc.

ASTH • Medical - Care Facilities

$38.47

▲ +0.64 (+1.69%)

Precio actual

ResultadosÚltimo reporte: 30 jun 2026

PERFIL EQUILIBRADONeutralConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Perfil mixto. La empresa no es necesariamente mala, pero la valoración, el crecimiento o el balance todavía no justifican una señal más fuerte.

Capitalización

$1.91B

Crecimiento

-75.5%

Flujo de caja

5/5

Tendencia

Stable

Evidencia

Crecimiento positivo de ingresos · 38.4%Flujo de caja libre positivo · 2.13Flujo de caja libre consistente · 5/5Liquidez saludable · 1.4Múltiplo de ganancias caro · 54.15

Datos financieros hasta: 30 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 12 ago 2026, 12:11 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$38.47

Change1.69%

Shares Out49.78M

Market Cap$1.91B

Enterprise Value$2.45B

52W Range18.08 - 51.60

Beta0.90

P/E47.23

P/S0.50

P/B2.31

P/FCF12.09

EV/Sales0.64

Price$38.47

Change1.69%

Shares Out49.78M

Market Cap$1.91B

Enterprise Value$2.45B

52W Range18.08 - 51.60

Beta0.90

P/E47.23

P/S0.50

P/B2.31

P/FCF12.09

EV/Sales0.64

EV/EBITDA15.22

EV/FCF15.47

Earnings Yield2.12%

FCF Yield8.27%

Dividend Yield0.10%

Gross Margin9.30%

Oper. Margin2.47%

Profit Margin0.71%

Debt/Eq1.38

Current Ratio1.40

Quick Ratio1.40

Revenue 5Y-75.54%

Target$51.80

Target Upside34.65%

Target Median$53.00

Target Range41.00 - 65.00

Volume584.22K

Avg Volume565.61K

EPS Surprise0.45

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

27/100

Fortaleza financiera

Deuda, caja, estabilidad

58/100

Potencial de crecimiento

Ingresos y expansión

95/100

Atractivo del precio

Barata o cara hoy

72/100

Por qué este puntaje▼

Crecimiento positivo de ingresos · 38.4%Flujo de caja libre positivo · 2.13Flujo de caja libre consistente · 5/5Liquidez saludable · 1.4Múltiplo de ganancias caro · 54.15Rentabilidad débil

Analyst view

Analyst sentiment and price target

ASTH

Analyst sentiment

Based on 10 analyst votes · 2026-09-05

100/100

Bullish

Hold

Bearish

Precio objetivo

2026-08-12

Bajo

$41.00

Promedio

$51.80

Mediana

$53.00

Alto

$65.00

Resumen de la compañía

IPO: 3/11/2009

Industria: Medical - Care Facilities

P/B i: 2.31

Deuda / Patrimonio i: 1.38

Margen operativo: 2.47%

Margen neto: 0.71%

ROE i: -

ROIC: -

Salud financiera

Puntaje12 / 20

Deuda / Patrimonio: 1.38

Ratio corriente: 1.40

Ratio rápido: 1.40

Estado: Good

Transacciones internas

Actividad reciente de ejecutivos e insiders

Sobotka Glenn

Transacción: 08/07/2026

VENTA

Cambio

-11,793

Precio

Not reported

Presentación

08/11/2026

Tipo

VENTA

Vong John

Transacción: 08/07/2026

OTRO

Cambio

Precio

Not reported

Presentación

08/11/2026

Tipo

OTRO

Sim Brandon

Transacción: 06/27/2026

VENTA

Cambio

-1,093

Precio

$44.51

Presentación

06/30/2026

Tipo

VENTA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
Sobotka Glenn	VENTA	-11,793	Not reported	08/07/2026	08/11/2026
Vong John	OTRO	0	Not reported	08/07/2026	08/11/2026
Sim Brandon	VENTA	-1,093	$44.51	06/27/2026	06/30/2026
Chiang John	COMPRA	+4,525	Not reported	06/10/2026	06/12/2026
Dai, Weili	COMPRA	+4,525	Not reported	06/10/2026	06/12/2026
Dong Linda	COMPRA	+4,525	Not reported	06/10/2026	06/12/2026
Kitayama Mitchell W	COMPRA	+4,991	Not reported	06/10/2026	06/12/2026
Mazdyasni Matthew	COMPRA	+4,525	Not reported	06/10/2026	06/12/2026
Schmidt David	COMPRA	+4,525	Not reported	06/10/2026	06/12/2026
Basho Chandan	VENTA	-8,155	$38.26	05/16/2026	05/18/2026
Basho Chandan	VENTA	-3,870	$29.07	04/14/2026	04/15/2026
Sim Brandon	COMPRA	+201,056	Not reported	04/06/2026	04/08/2026
Sim Kenneth T.	COMPRA	+100,000	Not reported	04/06/2026	04/08/2026
Lam Thomas S.	COMPRA	+41,667	Not reported	04/06/2026	04/08/2026
Basho Chandan	VENTA	-2,092	$25.05	04/02/2026	04/03/2026
Kumar Dinesh M.	VENTA	-57,980	$24.51	04/01/2026	04/03/2026
Sobotka Glenn	VENTA	-662	$24.27	03/26/2026	03/30/2026
Basho Chandan	VENTA	-1,240	$25.07	03/05/2026	03/09/2026
Kumar Dinesh M.	VENTA	-1,697	$25.07	03/05/2026	03/09/2026
Lam Thomas S.	VENTA	-9,266	$25.07	03/05/2026	03/09/2026

Sobre la compañía

Astrana Health, Inc.

Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.

Fuente - Link

Competidores

ACHC AVAH HCSG LFST MD MNKD NHC OMCL SEM USPH

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Astrana Health: 81% Full-Risk And Profitable

Astrana Health is rated a buy, trading at a 46% discount to peers despite sector-wide reserve releases clarifying earnings quality concerns. ASTH's Care Enablement platform drove G&A costs from 7.75% to 5.57% of revenue, quadrupling third-party revenue year-over-year and supporting durable profit at scale. Organic growth is driven by a mix-shift into full-risk capitation, with management projecting ongoing revenue-per-member expansion and a robust conversion pipeline.

Seeking Alpha

Astrana Health, Inc. (ASTH) Q2 2026 Earnings Call Transcript

Seeking Alpha

Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates

Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.4 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.19 per share a year ago.

Zacks Investment Research

Astrana Health Q2 Earnings Call Highlights

Astrana Health NASDAQ: ASTH reported second-quarter 2026 revenue of $973 million, up 49% from a year earlier, while adjusted EBITDA increased 43% to $69 million. Adjusted diluted earnings per share reached a record $0.80, up 45% year over year, as the company cited growth in value-based care arrangements, medical-cost management, Prospect Health acquisition synergies and operating leverage.

MarketBeat

Astrana Health, Inc. Reports Second Quarter 2026 Results

Company to Host Conference Call on Thursday, August 6, 2026, at 2:30 p.m. PT/5:30 p.m.

PRNewsWire

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-05-07	0.29	0.74	0.45
2026-03-02	0.15	0.54	0.39
2025-11-06	0.47	0.01	-0.46
2025-08-07	0.36	0.19	-0.17
2025-05-08	0.23	0.14	-0.09
2025-02-27	0.22	-0.15	-0.37
2024-11-07	0.32	0.33	0.01
2024-08-07	0.39	0.4	0.01
2024-05-07	0.3	0.31	0.01
2024-02-27	0.15	0.26	0.11
2023-11-07	0.27	0.47	0.2
2023-08-07	0.2491	0.28	0.0309